Anzeige
Mehr »
Montag, 02.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
158 Leser
Artikel bewerten:
(1)

Spot.See: SpotSee and Controlant Announce Strategic Collaboration to Expand Shipment Visibility and Last-Mile Proof for Life Sciences

DALLAS and REYKJAVÍK, Iceland, March 02, 2026 (GLOBE NEWSWIRE) -- SpotSee and Controlant today announced a strategic collaboration designed to help life sciences organizations expand shipment visibility, strengthen proof of condition and scale monitoring programs more efficiently across temperature-sensitive supply chains. The partnership brings together Controlant's real-time connected monitoring devices and SpotSee's scalable indicator technology with cloud analytics to help organizations increase confidence, strengthen proof of condition and support more cost-effective monitoring programs.

Together, the companies enable a layered monitoring approach that combines real-time device data with shipment-level indicators, allowing customers to extend coverage, improve last-mile verification and optimize monitoring investments across shipment portfolios with ease.

As part of the collaboration, a co-branded Controlant Go device is available now, simplifying real-time monitoring and connectivity for high-value shipments. In addition, the companies are also developing an integration between WarmMark QR indicators and the Controlant cloud platform, planned for release this year, enabling QR-based temperature indicator data to feed directly into cloud visibility and quality workflows.

"This collaboration closes the monitoring gaps from pallet to patient," said SpotSee CEO Tony Fonk. "By combining last-mile, indicator-based monitoring with real-time connected devices and cloud analytics, customers can build programs that reduce returns by as much as 90% and significantly improve patient satisfaction."

"The market is clear: customers need automated data sharing and continuous, end-to-end visibility," said Controlant CEO Gísli Herjólfsson. "By working with SpotSee, we can extend monitoring strategies beyond devices alone and support last-mile proof that's ready to scale from day one without the heavy lifting."

The joint ecosystem is designed for pharmaceutical manufacturers, specialty logistics providers and cold chain operators seeking to reduce risk, improve delivery verification and expand monitoring coverage across global shipment networks.

The companies are now rolling out joint customer engagement and program deployment.

About SpotSee
At SpotSee, every degree matters. As a global leader in impact and condition monitoring and sensing solutions, the company helps customers identify changing conditions to protect life sciences and ensure supply chain integrity. SpotSee provides products that enable more than 4,500 customers and partners in 62 countries to detect changes in the condition of everything from vaccines to spaceships. The company's solutions include temperature, impact, tilt, vibration, humidity and liquid detection monitoring devices, available via visual, RFID, QR code, cellular or satellite connection. Its products such as WarmMark, ColdMark, HemoTemp II, ThermoStrip, Thermax, BriteLine, ShockWatch, ShockLog and TiltWatch are widely used in the life sciences, energy, transportation, aerospace, defense, food, manufacturing and consumer products sectors. The company is headquartered in Dallas, Texas, and operates five facilities in Texas, Illinois, Mexico and the United Kingdom. For more information, visit www.spotsee.io.

About Controlant
Controlant is a global leader in real-time supply chain visibility for the life sciences industry, making it easy for pharmaceutical manufacturers and logistics providers safeguard product quality, ensure compliance and reduce waste across global distribution networks. The company's platform integrates validated IoT monitoring devices, cloud-based analytics and automated workflows to enable proactive excursion management, audit-ready reporting and data-driven decision-making. Headquartered in Iceland, Controlant supports digitally connected supply chains from manufacturing through last-mile delivery, helping customers increase resilience, improve efficiency and advance sustainability goals. For more information, visit www.controlant.com.



Contact: Bethany Hilt Phone: +13303386633 Email: hiltb@hiltstrategiccommunications.com

© 2026 GlobeNewswire (Europe)
Tech-Aktien schwanken – 3 Versorger mit Rückenwind
Die Stimmung an den Märkten hat sich grundlegend gedreht. Während Tech- und KI-Werte zunehmend mit Volatilität und Bewertungsrisiken kämpfen, erleben klassische Versorger ein unerwartetes Comeback. Laut IEA und EIA steigt der globale Strombedarf strukturell weiter, nicht nur wegen E-Mobilität und Wärmepumpen, sondern vor allem durch energiehungrige KI-Rechenzentren. Energie wird damit zur zentralen Infrastruktur des digitalen Zeitalters.

Gleichzeitig rücken in unsicheren Marktphasen stabile Cashflows, solide Bilanzen und regulierte Renditen wieder stärker in den Fokus. Genau hier spielen Versorger ihre Stärken aus: berechenbare Erträge, robuste Nachfrage und hohe Dividenden – Qualitäten, die vielen Wachstumswerten aktuell fehlen.

Nach Jahren im Schatten der Tech-Rallye steigt nun das Interesse an Unternehmen, die Stabilität mit langfristigen Wachstumsthemen wie Netzausbau, Dekarbonisierung und erneuerbaren Energien verbinden.

Im aktuellen Spezialreport stellen wir drei Versorger vor, die defensive Stärke mit attraktivem Potenzial kombinieren.

Jetzt den kostenlosen Report sichern – bevor die nächste Versorgerwelle Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.